Day One at GCC 2026: Where the Conversation Shifted
There are moments when a conversation changes direction, and you can feel it in the room.
Day One of the Global Conversations & Connections (GCC) Summit did exactly that.
From the opening sessions to the final discussions of the day, one theme was clear: the future of global health will not be built for Africa; it will be built with Africa as an essential partner.
Reframing the Investment Narrative
The day began by confronting one of the most critical (and often avoided) questions: what does it take to make African research truly investable?
The Investment Imperative session set the tone, shifting the conversation from potential to execution, highlighting the real conditions required to move research from publishable to bankable.
Leaders across academia, industry, and entrepreneurship explored where breakdowns occur between research, capital, and commercialization, and what must change to unlock long-term investment.
“Investment is the bottleneck. Without a clear path to investment or a supportive ecosystem, ideas don’t move, they don’t scale, and most importantly, they don’t reach the people they’re intended to serve.”
Daniel Kontoh-Boateng, Founder, DKB Partners
From Participation to Scientific Leadership
Across sessions, the conversation moved beyond access and inclusion and into scientific necessity.
In Scientific Necessity: Optimizing Drug Development for African Populations, speakers challenged the industry to rethink how therapies are developed, emphasizing that excluding African populations creates critical gaps in safety, efficacy, and innovation.
Reimagining Clinical Research Ecosystems
The conversation continued with a deeper look at how clinical research is evolving across the continent.
In Architects of Equity, leaders explored what it means to move from research participation to research leadership by centering trust, health literacy, and partnership as foundational to building sustainable, Africa-led research ecosystems.
The discussion reinforced a critical shift: Africa is not a site for research – it is a driver of it.
“We are not talking about doing for Africa. We are talking about doing with Africa — with the scientists, with the innovators, with the communities on the continent.”
— Monique Adams, Executive Director, Global Head of Diversity, Inclusion & Clinical Trials, Sanofi
Building the Infrastructure for What’s Next
Day One also spotlighted the operational realities of scaling innovation.
From manufacturing to infrastructure, sessions examined what it takes to build systems that can support long-term growth—not just isolated breakthroughs.
In Scaling High-Complex Manufacturing Across Emerging Markets, the conversation focused on the transition from basic production to advanced bioproduction, highlighting how technology, partnerships, and local capacity are reshaping what’s possible.
What made Day One distinct was the alignment. Across sessions, leaders weren’t just describing challenges. They were outlining solutions, sharing real decisions, and engaging with the complexity of building something new.
For those in the room, it was clear: this is not a future conversation. It’s already happening.
